Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Pieris Pharmaceuticals, Inc. PIRS

Set alert

Price alert · PIRS

All alert types
13.60 0.00 0.00%

At close · Dec 13

13.26 Day range 15.35

52-week range unavailable

Open
15.04
Prev close
13.60
Mkt cap
17.96M
Vol
51.73K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
13.26
High
15.35
Forward P/E
-68.00
Beta
0.66
Short ratio
3.52
Inst. own
52.92%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2024
50-d avg
16.46
200-d avg
14.03
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PIRS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.7×
FY 2016: -2.6×FY 2017: -18.8×FY 2018: -5.3×FY 2019: -7.7×FY 2020: -3.7×FY 2021: -5.6×FY 2022: -2.5×FY 2023: -0.7×FY 2024: -1.7×FY 2025: -3.7×
FY 2016 5y median -2.5× FY 2025
P/S 0.0×
FY 2016: 10.1×FY 2017: 13.1×FY 2018: 4.9×FY 2019: 4.0×FY 2020: 4.6×FY 2021: 7.8×FY 2022: 3.0×FY 2023: 0.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.4× FY 2025
P/B 5.5×
FY 2016: 2.3×FY 2017: 28.8×FY 2018: 3.5×FY 2019: 3.6×FY 2020: 4.4×FY 2021: 4.8×FY 2022: 2.8×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 5.5×
FY 2016 5y median 2.8× FY 2025
P/FCF -6.1×
FY 2016: -3.9×FY 2017: 6.9×FY 2018: -51.1×FY 2019: -3.3×FY 2020: -2.8×FY 2021: -28.3×FY 2022: -1.3×FY 2023: -0.3×FY 2024: -2.8×FY 2025: -6.1×
FY 2016 5y median -2.8× FY 2025
EV/EBITDA 0.0×
FY 2016: -1.3×FY 2017: -20.7×FY 2018: -2.2×FY 2019: -5.3×FY 2020: -2.6×FY 2021: -3.1×FY 2022: -1.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
EV/Sales 0.0×
FY 2016: 5.0×FY 2017: 11.6×FY 2018: 2.3×FY 2019: 3.0×FY 2020: 2.8×FY 2021: 4.5×FY 2022: 2.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -16.3%
FY 2016: -25.5%FY 2017: 14.4%FY 2018: -2.0%FY 2019: -30.0%FY 2020: -35.7%FY 2021: -3.5%FY 2022: -79.0%FY 2023: -329.4%FY 2024: -35.8%FY 2025: -16.3%
FY 2016 5y median -35.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: -18.8%FY 2020: -58.7%FY 2021: 92.5%FY 2022: 89.3%FY 2023: 2.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 2.4% FY 2025
Operating Margin 0.0%
FY 2016: -390.3%FY 2017: -57.7%FY 2018: -105.9%FY 2019: -58.7%FY 2020: -115.7%FY 2021: -165.0%FY 2022: -167.8%FY 2023: -69.5%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -69.5% FY 2025
Net Margin 0.0%
FY 2016: -391.0%FY 2017: -69.8%FY 2018: -91.9%FY 2019: -51.3%FY 2020: -127.0%FY 2021: -138.0%FY 2022: -120.7%FY 2023: -57.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -57.3% FY 2025
ROE -149.1%
FY 2016: -90.4%FY 2017: -153.2%FY 2018: -67.0%FY 2019: -46.3%FY 2020: -120.0%FY 2021: -85.4%FY 2022: -111.9%FY 2023: -91.7%FY 2024: -27.8%FY 2025: -149.1%
FY 2016 5y median -91.7% FY 2025
ROIC 0.0%
FY 2016: -85.3%FY 2017: -25.1%FY 2018: -32.7%FY 2019: -23.7%FY 2020: -40.4%FY 2021: -49.8%FY 2022: -72.7%FY 2023: -111.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -49.8% FY 2025
ROA -70.0%
FY 2016: -65.0%FY 2017: -17.0%FY 2018: -18.9%FY 2019: -16.8%FY 2020: -35.5%FY 2021: -28.2%FY 2022: -32.7%FY 2023: -63.5%FY 2024: -19.8%FY 2025: -70.0%
FY 2016 5y median -32.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 98.9%FY 2017: 333.5%FY 2018: 15.1%FY 2019: 59.0%FY 2020: -36.6%FY 2021: 7.1%FY 2022: -17.6%FY 2023: 65.3%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 0.0%
FY 2016: -66.4%FY 2017: 35.9%FY 2018: -111.3%FY 2019: 11.9%FY 2020: -24.9%FY 2021: -52.8%FY 2022: 16.1%FY 2023: 31.6%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 FY 2025
EPS (diluted) 52.6%
FY 2016: -33.7%FY 2017: 26.5%FY 2018: -25.5%FY 2019: 6.9%FY 2020: -45.6%FY 2021: 1.7%FY 2022: 37.3%FY 2023: 35.3%FY 2024: 64.1%FY 2025: 52.6%
FY 2016 FY 2025
Free Cash Flow -130.7%
FY 2016: -12.3%FY 2017: 419.4%FY 2018: -105.8%FY 2019: -1887.3%FY 2020: 11.5%FY 2021: 82.3%FY 2022: -608.2%FY 2023: 11.5%FY 2024: 79.9%FY 2025: -130.7%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 3.9×FY 2017: 2.0×FY 2018: 2.8×FY 2019: 4.3×FY 2020: 3.4×FY 2021: 2.5×FY 2022: 2.0×FY 2023: 3.2×FY 2024: 7.3×FY 2025: 5.2×
FY 2016 5y median 3.2× FY 2025
Quick Ratio 5.2×
FY 2016: 3.9×FY 2017: 2.0×FY 2018: 2.8×FY 2019: 4.3×FY 2020: 3.4×FY 2021: 2.5×FY 2022: 2.0×FY 2023: 3.2×FY 2024: 7.3×FY 2025: 5.2×
FY 2016 5y median 3.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.5×FY 2021: 0.3×FY 2022: 0.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 1.3×FY 2017: 2.7×FY 2018: 2.5×FY 2019: 1.8×FY 2020: 1.7×FY 2021: 2.3×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31